Asset

Total 208, page 2/11

No. Organization Therapeutic Area Product Type Title
138 University of California - Los Angeles Oncology Small molecule Monoamine Oxidase Blockade Therapy for Treating Cancer
137 University of California - Los Angeles Oncology Cell therapy Use of COX2 Knock Out Monocytes and Osteoclasts to Activate and Expand NK Cells
136 University of California - Los Angeles Oncology Small molecule Protein Kinase Inhibitors Which Also Target Dihydroorotate Dehydrogenase
135 University of Basel Oncology Gene therapy Treatment of Malignant Neoplasms
134 Stanford University Genetic disorders Gene therapy Multiplexed Gene Editing and Control with Enhanced Cas12a
133 SaxoCell Oncology Nanoparticle Polymeric Nanoparticle Platform Technologies for RNA & Gene Therapeutics
132 QIMR Oncology Antibody Galectin-9 Targeting Monoclonal Antibody for Solid Tumours
131 QIMR Oncology Cell therapy ‘Off-the-Shelf’ CMV EphA3 CAR T Cell Therapy for Solid Tumours
130 Oregon Health and Science University Cardiovascular disease Small molecule Compositions for Treatment of Neurological and Oxidative Stress Disorders
129 Oregon Health and Science University Neurology Small molecule Small Molecules Promoting Nerve Regeneration
128 Oregon Health and Science University Oncology Small molecule Small Molecule Activates Innate Immune Responses Controlled by the Human Protein STING
127 Oregon Health and Science University Oncology Small molecule A First in Class Small Molecule as a Novel YB1 Inhibitor
126 Northwestern University Oncology Protein A Novel Strategy to Block Mitotic Progression for Target Therapy
125 Northwestern University Oncology Small molecule Gold(III) Metformin and Phenformin Prodrugs
124 National Tsing Hua University Neurology, CNS disease Small molecule First-in-Class α6GABAA-Selective Modulators for Migraine and Other disorders
123 Massachusetts Institute of Technology Oncology Small molecule Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis
122 Massachusetts Institute of Technology Oncology Small molecule Identification of Gpd2 and Scl1a5 as Therapeutic Targets in Lung Cancers with Mutations in the Oxidative Stress Pathway
121 Massachusetts Institute of Technology Inflammatory disease Antibody Development of Multi-Specific Antibody-Serum Albumin Fusion Proteins Targeting Multiple Human and Murine CXC (ELR+) Chemokines
120 Max-Planck Innovation Oncology Peptide A Novel Inhibitor Targeting Matrix Accumulation in Cancer
119 Lead Discovery Center Inflammatory disease Small molecule CSF1-Receptor Inhibitors

TOP